Skip to main content

Cooperative partnerships or conflict-of-interest? A national survey of interaction between the pharmaceutical industry and medical organizations

Buy Article:

$43.00 plus tax (Refund Policy)

Abstract Background: 

There is extensive and varied interaction between the pharmaceutical industry and the medical profession. Most empirical research concerns contact between individual physicians and industry, and reflects North American experience. We sought to clarify the extent and nature of relationships between the pharmaceutical industry and Australian medical organizations. Methods: 

We administered questionnaires to 63 medical organizations concerned with clinical practice, continuing medical education or professional accreditation, or the political representation of medical professionals. Results: 

Survey instruments were received from 29 organi¬≠zations, giving a response rate of 46%. Seventeen of these organizations (59%) had received support from one or more pharmaceutical company in the past financial year. Support was predominantly for annual conferences, with some support for continuing medical education, research, travel and library purchases. The majority of organizations had an academic journal or newsletter, and 10 (34%) accepted revenue from pharmaceutical advertising. Twenty organizations (72%) had policies or guidelines covering their relationship with industry. Few organizations indicated that they would be unable to continue their activities without pharmaceutical industry support. Conclusion: 

These data indicate a high level of inter¬≠action between the pharmaceutical industry and medical organizations in Australia. While most organizations have policies for guiding their relationship with industry, it is unclear whether these are effective in preventing conflicts of interest and maintaining public trust. (Intern Med J 2005; 35: 206–210)
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: conflict-of-interest; ethics; influence; medicine; pharmaceutical industry

Document Type: Research Article

Affiliations: 1: Centre for Values, Ethics and the Law in Medicine, University of Sydney 2: Discipline of Clinical Pharmacology, School of Medical Practice and Population Health 3: School of Biomedical Sciences, University of Newcastle 4: School of Public Health and Community Medicine 5: Department of Physiology and Pharmacology, School of Medical Sciences, Faculty of Medicine, University of New South Wales 6: Merck Sharp and Dohme (Australia), Sydney, New South Wales, Australia

Publication date: 2005-04-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more